Catalyst Pharmaceuticals names new CEO, shares down
19/10/2023 14:46
** Shares of drug developer Catalyst Pharmaceuticals Inc
CPRX.O down 2.9% at $12.91
** Co appoints Richard J. Daly as CEO, effective Jan. 1,
2024
** Patrick J. McEnany will retire from CEO position,
effective Dec. 31, but will continue in his role as chairman of
the board
** CPRX shares down 28.5% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))